GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mersana Therapeutics Inc (STU:0M4) » Definitions » Other Gross PPE

Mersana Therapeutics (STU:0M4) Other Gross PPE : €13.96 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mersana Therapeutics Other Gross PPE?

Mersana Therapeutics's Other Gross PPE for the quarter that ended in Dec. 2024 was €13.96 Mil.

Mersana Therapeutics's quarterly Other Gross PPE declined from Jun. 2024 (€8.54 Mil) to Sep. 2024 (€7.20 Mil) but then increased from Sep. 2024 (€7.20 Mil) to Dec. 2024 (€13.96 Mil).

Mersana Therapeutics's annual Other Gross PPE declined from Dec. 2022 (€19.24 Mil) to Dec. 2023 (€16.64 Mil) and declined from Dec. 2023 (€16.64 Mil) to Dec. 2024 (€13.96 Mil).


Mersana Therapeutics Other Gross PPE Historical Data

The historical data trend for Mersana Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mersana Therapeutics Other Gross PPE Chart

Mersana Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.90 19.05 19.24 16.64 13.96

Mersana Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.64 9.53 8.54 7.20 13.96

Mersana Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Mersana Therapeutics Business Description

Traded in Other Exchanges
Address
840 Memorial Drive, Cambridge, MA, USA, 02139
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Mersana Therapeutics Headlines

No Headlines